"MSK Rockville Centre is proud to have served the residents of Nassau County and surrounding communities since 1997. As of Monday, April 8, MSK Rockville Centre staff and services will relocate to MSK Nassau in Uniondale, located 4 miles away. For general information, call Memorial Sloan Kettering at 212-639-2000, 24 hours a day, seven days a week. To make an appointment, call us at 800-525-2225, Monday through Friday between 8:30 AM and 5:30 PM ET."

During the past decade, Memorial Sloan-Kettering at Mercy Medical Center conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 47 clinical trials were completed, i.e. on average, 72.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 30 clinical trials were completed. i.e. 1000% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Memorial Sloan-Kettering at Mercy Medical Center" #1 sponsor was "Memorial Sloan Kettering Cancer Center" with 102 trials, followed by "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "Radiation Therapy Oncology Group" with 5 trials sponsored, "Pfizer" with 3 trials sponsored and "Dana-Farber Cancer Institute" with 3 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Sloan-Kettering at Mercy Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 16 trials as a collaborator, "M.D. Anderson Cancer Center" with 5 trials as a collaborator, "Dana-Farber Cancer Institute" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator and "National Comprehensive Cancer Network" with 4 trials as a collaborator. Other collaborators include 141 different institutions and companies that were collaborators in the rest 108 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Sloan-Kettering at Mercy Medical Center" are "Breast Cancer" (11 trials), "Prostate Cancer" (11 trials), "Lung Cancer" (10 trials), "Head and Neck Cancer" (7 trials) and "Gastric Cancer" (5 trials). Many other conditions were trialed in "Memorial Sloan-Kettering at Mercy Medical Center" in a lesser frequency.

Most popular intervention types in "Memorial Sloan-Kettering at Mercy Medical Center" are "Drug" (86 trials), "Radiation" (33 trials), "Other" (17 trials), "Behavioral" (11 trials) and "Procedure" (10 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (5 trials), "Carboplatin" (4 trials), "Cisplatin" (4 trials), "Placebo" (4 trials) and "cisplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Sloan-Kettering at Mercy Medical Center" are 91 trials for "All" genders, 21 trials for "Female" genders and 11 trials for "Male" genders.

Currently, there are NaN active trials in "Memorial Sloan-Kettering at Mercy Medical Center". undefined are not yet recruiting, 8 are recruiting, 42 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Memorial Sloan-Kettering at Mercy Medical Center, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Sloan-Kettering at Mercy Medical Center, 26 "Phase 1" clinical trials were conducted, 69 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".